PRN Meeting: February 23, 2022 Jointly provided by the Medical Society of the State of New York, at a Zoom webinar, 7:00 p.m. to 9:00 p.m (EST).

Target Audience:

Physicians, Nurse Practitioners, and Physician Assistants caring for people at risk for, or infected with HIV and/or viral hepatitis.

Course Director: James F. Braun, DO, President, Physicians' Research Network

Moderator: William M. Valenti, MD, Chair, Infectious Diseases Committee of the Medical Society of the State of New York

Guest Speakers and Presentations:

Healthy Aging with HIV in the Context of COVID-19

Giovanni Guaraldi, MD

Associate Professor
Department of Surgical, Medical, Dental and Morphological Sciences
University of Modena and Reggio Emilia, Modena, Italy

Learning Objectives:

At the completion of this educational session, participants will:
1. Be introduced to the principles of HIV geriatric medicine and understand that healthy aging is the ultimate goal of HIV management.
2. Learn how to assess biological age with frailty and recognize the changing clinical pattern of people aging with HIV versus people who acquired HIV at an older age.
3. Appreciate, in the context of COVID pandemic, different models of HIV care in older adults, in PLWH experiencing frailty transition and in elderly frail individuals.
4. Understand antiretroviral therapy management within the framework of polypharmacy deprescribing strategies.

Rapid Initiation of HIV Antiretroviral Treatment (RIA)

Antonio E. Urbina, MD

Professor of Medicine, Icahn School of Medicine
Medical Director, Institute for Advanced Medicine
Mount Sinai Hospital, New York, NY

Learning Objectives:

At the completion of this educational session, participants will:
1. Understand the evidence that supports the need for early diagnosis and linkage to care of people with HIV infection.
2. Know how to identify safe and efficacious rapid ART regimens based on known patient characteristics, as well as regimens to avoid.
3. Be able to address treatment barriers to providing rapid ART to all patients in HIV care.

Accreditation Statement: This activity has been planned and implemented in accordance with the Accreditation Requirements and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). The Medical Society of the State of New York (MSSNY) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing Medical Education for physicians.

The Medical Society of the State of New York (MSSNY) designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Statement:

Dr. Braun (Planner/Course Director) has no relevant financial relationships to disclose. Dr. William M. Valenti (Moderator) has no relevant financial relationships to disclose. Dr. Giovanni Guaraldi (Presenter) has had the following personal financial relationships in the past 24 months with manufacturers of the products or services that may be presented in this CME activity: Grant Recipient from Gilead, ViiV, Merck, and Janssen; Honorarium Recipient from Gilead, ViiV, Merck, and Janssen; Speaker Participant for Gilead, ViiV, Merck, and Janssen.  Dr. Guaraldi will support his presentation and clinical recommendations with the best available evidence from the medical literature, and will submit his slides in advance for adequate peer review. Dr. Antonio E. Urbina (Presenter) has had the following personal financial relationships in the past 24 months with manufacturers of the products or services that may be presented in this CME activity: Consultant to Janssen; Sponsored Research from Gilead; Scientific Advisory Panelist for ViiV, Merck, and Gilead. Dr. Urbina will support his presentation and clinical recommendations with the best available evidence from the medical literature, and will submit his slides in advance for adequate peer review.

Financial Support:

This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; ViiV Healthcare; others pending.